SEC Info - Arena Pharmaceuticals Inc - ‘8-K’ for 8/25/10

SEC Info℠

Home

Help

Please Sign In

Arena Pharmaceuticals Inc – ‘8-K’ for 8/25/10 – EX-16.1

On: Monday, 8/30/10, at 4:27pm ET · For: 8/25/10 · Accession #: 1193125-10-200627 · File #: 0-31161

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/30/10  Arena Pharmaceuticals Inc         8-K:4,9     8/25/10    2:23K                                    RR Donnelley/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     21K 
 2: EX-16.1     Letter From Ernst & Young LLP to SEC Dated August   HTML      5K 
                          27, 2010

EX-16.1 — Letter From Ernst & Young LLP to SEC Dated August 27, 2010

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Letter from Ernst & Young LLP to SEC dated August 27, 2010

Exhibit 16.1

August 27, 2010

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 4.01 of Form 8-K dated August 25, 2010, of Arena Pharmaceuticals, Inc. and are in agreement with the statements contained in the second sentence of paragraph 1 and paragraphs 2, 3, 4, 5 and 6 in Item 4.01 (a) therein. We have no basis to agree or disagree with other statements of the registrant contained therein.

/s/ Ernst & Young LLP

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

Filed on:	8/30/10	None on these Dates
	8/27/10
For Period End:	8/25/10
		List all Filings

↑Top

Filing Submission 0001193125-10-200627 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)